Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A
NCT07229820 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 157
Last updated 2025-12-16
Summary
This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Conditions
Interventions
- DRUG
-
ZSP1273
Oral
- DRUG
-
Oral
Sponsors & Collaborators
-
Guangdong Raynovent Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-08
- Primary Completion
- 2025-12-22
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.
NCT03679143 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
NCT06669351 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
NCT07229547 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
NCT07095257 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
NCT00979667 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
NCT01231620 ·Status: COMPLETED ·Phase: PHASE3
-
Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males
NCT01428479 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza
NCT06507813 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
NCT01459081 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection
NCT05507489 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms
NCT06774859 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3
-
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants
NCT05257798 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
NCT04729764 ·Status: COMPLETED ·Phase: PHASE1
-
The Benefit and Harm of Fever Suppression by Antipyretics in Influenza
NCT01891084 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Remdesivir in Adults With Severe COVID-19
NCT04257656 ·Status: TERMINATED ·Phase: PHASE3
-
ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection
NCT06342921 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
NCT06643156 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
NCT04982913 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
NCT04706468 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
NCT00705406 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children
NCT05381363 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
NCT00486980 ·Status: WITHDRAWN ·Phase: PHASE3